Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors

Go back to Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 1.10 +0.01 (0.92%)
Previous Close $1.09    52 Week High $13.20 
Open $1.09    52 Week Low $7.00 
Day High $1.14    P/E N/A 
Day Low $1.09    EPS $0.00 
Volume 1,845,836